Boston Scientific
926 hedge funds and large institutions have $60.3B invested in Boston Scientific in 2022 Q4 according to their latest regulatory filings, with 143 funds opening new positions, 328 increasing their positions, 313 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5% more repeat investments, than reductions
Existing positions increased: 328 | Existing positions reduced: 313
2.05% less ownership
Funds ownership: 93.24% → 91.19% (-2%)
33% less call options, than puts
Call options by funds: $203M | Put options by funds: $303M
Holders
926
Holding in Top 10
28
Calls
$203M
Puts
$303M
Top Buyers
| 1 | +$825M | |
| 2 | +$351M | |
| 3 | +$296M | |
| 4 |
SCM
Steadfast Capital Management
New York
|
+$130M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$111M |
Top Sellers
| 1 | -$1.13B | |
| 2 | -$345M | |
| 3 | -$287M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$208M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$185M |